Back
Open Access

Efficacy and safety of ticagrelor versus clopidogrel in acute myocardial infarction-associated cardiogenic shock: a propensity score-matched analysis

Session: Cardiogenic shock
Topic: Cardiogenic Shock
Speaker: Doctor M. Presume (Lisbon, PT)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Marcia Presume

Hospital Santa Cruz, Lisbon (Portugal)
0 follower

6 more presentations in this session

Anti-thrombotic therapy for AMI-CS on mechanical circulatory support: do we need DAPT?

Speaker: Doctor R. Carvalho (Lisbon, PT)

Access
Abstract
Like
Thumbnail

Unveiling the population dynamics of sepsis cardiomyopathy: a comprehensive evaluation

Speaker: Doctor C. Gregorio (Lisbon, PT)

Access
Abstract
Like
Thumbnail

The relationship between ventricular conduction blocks and biomarker levels in cardiogenic shock patients

Speaker: Miss E. Hynninen (Helsinki, FI)

Access
Abstract
Like
Thumbnail

The heart-kidney connection: acute kidney injury in cardiogenic shock

Speaker: Doctor R. Carvalho (Lisbon, PT)

Access
Abstract
Like
Thumbnail

Cardiogenic shock causes variability in all-comers unselected population

Speaker: Doctor V. Dragona (Athens, GR)

Access
Abstract
Like
Thumbnail

Access the full session

Cardiogenic shock

Speakers: Doctor M. Presume, Doctor R. Carvalho, Doctor C. Gregorio, Miss E. Hynninen, Doctor R. Carvalho...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources